Found: 10
Select item for more details and to access through your institution.
Long-term safety and efficacy of erenumab in patients with chronic migraine: Results from a 52-week, open-label extension study.
- Published in:
- 2020
- By:
- Publication type:
- journal article
The spectrum of response to erenumab in patients with chronic migraine and subgroup analysis of patients achieving ≥50%, ≥75%, and 100% response.
- Published in:
- 2020
- By:
- Publication type:
- journal article
Long-term tolerability and nonvascular safety of erenumab, a novel calcitonin gene-related peptide receptor antagonist for prevention of migraine: A pooled analysis of four placebo-controlled trials with long-term extensions.
- Published in:
- 2019
- By:
- Publication type:
- journal article
Efficacy and safety of erenumab (AMG334) in chronic migraine patients with prior preventive treatment failure: A subgroup analysis of a randomized, double-blind, placebo-controlled study.
- Published in:
- 2018
- By:
- Publication type:
- journal article
An Investigation into the Prevalence of Migraine and Its Prophylactic Treatment Patterns in the Czech Republic: An Observational Study.
- Published in:
- Journal of Pain Research, 2020, v. 13, p. 2895, doi. 10.2147/JPR.S273119
- By:
- Publication type:
- Article
Early Use of Erenumab vs Nonspecific Oral Migraine Preventives: The APPRAISE Randomized Clinical Trial.
- Published in:
- JAMA Neurology, 2024, v. 81, n. 5, p. 461, doi. 10.1001/jamaneurol.2024.0368
- By:
- Publication type:
- Article
A phase 2, randomized, double-blind, placebo-controlled trial of AMG 301, a pituitary adenylate cyclase-activating polypeptide PAC1 receptor monoclonal antibody for migraine prevention.
- Published in:
- Cephalalgia, 2021, v. 41, n. 1, p. 33, doi. 10.1177/0333102420970889
- By:
- Publication type:
- Article
Primarni bolesti hlavy: Část I. Klasifikace primárních bolestí hlavy a migréna.
- Published in:
- Medicina po Promoci, 2018, v. 19, n. 3, p. 228
- By:
- Publication type:
- Article
Long‐term efficacy and safety of erenumab in patients with chronic migraine in whom prior preventive treatments had failed: A subgroup analysis.
- Published in:
- Headache: The Journal of Head & Face Pain, 2022, v. 62, n. 5, p. 624, doi. 10.1111/head.14313
- By:
- Publication type:
- Article
Galcanezumab in Patients with Multiple Previous Migraine Preventive Medication Category Failures: Results from the Open-Label Period of the CONQUER Trial.
- Published in:
- 2021
- By:
- Publication type:
- journal article